102585-27-3Relevant academic research and scientific papers
Solution-phase synthesis of ICG-001, a β-turn peptidomimetic molecule inhibitor of β-catenin-Tcf-mediated transcription
Piergentili, Alessandro,Del Bello, Fabio,Gentili, Francesco,Giannella, Mario,Quaglia, Wilma,Vesprini, Cristian,Thomas, Russell J.,Robertson, Graeme M.
, p. 12912 - 12916 (2007)
The solution-phase synthesis of the β-turn peptidomimetic ICG-001, a selective inhibitor of Wnt/β-catenin signalling, which has been found to be important for both initiation and progression of cancers of different tissues and has been exploited as an ext
SUPPRESSION AND REGENERATION PROMOTING EFFECT OF LOW MOLECULAR WEIGHT COMPOUND ON CANCER AND FIBROSIS
-
Paragraph 0125, (2019/02/28)
To obtain a novel therapeutic drug for a malignant tumor or fibrosis. Used is a compound represented by formula (1), a salt thereof, or a solvate thereof. Also used is a therapeutic drug for a malignant tumor or a therapeutic drug for fibrosis, comprising
